Generic name |
deferiprone |
---|---|
Strength |
100 mg/mL, 1000 mg |
Form |
oral solution, tablet |
Special Authority criteria |
Approval period |
---|---|
Treatment of transfusion-dependent iron overload due to thalassemia syndromes, where iron chelation therapy is required, according to established criteria*, and when prescribed by a hematologist. |
Initial request: 1 year Renewal request: 1 year |
* Click on the Special Authority Form below for full criteria: